Skip to main contentSkip to footer

At-home hydrogen breath testing

Ending Guesswork in Gut Health

Diagestics is developing an affordable home hydrogen breath-testing platform built around a compact reader and single-use sensor cartridges.

Hero

The opportunity

A simpler path to repeated breath testing

Current clinic-based testing can be costly, slow, and inconvenient. Diagestics is being developed as a lower-cost home alternative using disposable cartridges.

01

Home-first model

A compact reader designed for convenient use outside the clinic.

02

Single-use cartridges

Sealed cartridges designed around proprietary hydrogen sensing.

03

Recurring revenue

A reader-and-cartridge business model with recurring cartridge purchases.

The Diagestics solution

Precision gut-health testing, designed for home use

The development program combines a low-cost electronic reader with pre-packaged sensor cartridges and food substrates.

Sensor prototypes fabricated and in testing
Electronics design complete
Preliminary device and cartridge design complete
DIAGESTICS system

Business model

Low-cost reader. Recurring cartridge revenue.

The investor deck presents a razor-and-blade model intended to reduce the initial barrier to adoption while generating recurring cartridge revenue.

DIAGESTICS reader
$20–$30

Reader Device
One-time fee · target 50% margin

Cartridge
$5–$10

Disposable Cartridge
Recurring revenue · target 80% margin

Development roadmap

Building toward validation and market entry

The current company roadmap combines product development, pilot deployment, clinical studies, manufacturing partnerships, and regulatory planning.

Product design and testing complete
100 pilot units ready to deploy
Begin limited trials

Trials complete and manufacturing partner identified

Raising a $3M seed round

Diagestics is seeking investment to support a two-year development runway including design optimization, prototype manufacturing, testing, validation, and market preparation.

Product is under development and is not currently offered for sale. This prototype is for company and investor information only.